One other potential thing that may arise is that I don’t know if you can go into next year with the assumption that Jobe and Olson will be contributing much. Jobe obviously coming off the surgery, but Olson has an injury history that’s piling up. Odds that the two of them will be full strength for a lot of the year is slim. Same with SGL.
Should Flaherty leave, we may need to spend a good amount of capital just to fill out next years rotation beyond Skubal and Mize or risk being uncompetitive.